NASA’s October 12 preview of SpaceX’s 35th commercial resupply mission lists four health investigations: human-brain organoids, fungal crop disease, a compact biomarker reader and a returning study of antibiotic-resistant organisms.
The brain experiment sends small lab-grown tissue models to the station for five weeks and compares them with identical controls on Earth. The crop study infects Earth-grown and station-grown plants with the same disease-causing fungus, then compares molecular and structural changes. Both use microgravity as a controlled stress environment; neither has reported a result yet.
The compact microplate reader is the more operational story. It is designed to measure antibodies, antigens and proteins aboard the station, so scientists can get data without waiting for samples to return to Earth. The antibiotic-resistance study, on its fourth and final planned station stay, has astronauts repeatedly sample station surfaces to track how drug-resistant organisms survive and evolve.
The common constraint is logistics. On a long mission, diagnosis, crop protection and infection surveillance cannot all depend on a sample’s return ticket. These experiments test parts of the local measurement stack before that dependence becomes impossible.
NASA Science — “NASA’s SpaceX CRS-35 Mission to Launch Health Research,” October 12